Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on November 30th, 2023%
A developer of medical monitoring systems with data from wearable devices will soon start asking individuals with epilepsy to offer data for an algorithm that predicts seizures. . . . → Read More: Study to Provide Real World Data for A.I. Seizure Forecasts
By Alan, on November 29th, 2023%
A new challenge competition from XPrize calls for proactive and accessible health care solutions for improving the quality of life among older people worldwide. . . . → Read More: $101M Challenge Seeks Healthy Aging Solutions
By Alan, on November 28th, 2023%
A developer of messenger RNA therapies for respiratory and rare diseases says it received clearance to begin a clinical trial in the U.K. for an inhaled treatment for viral lung conditions. . . . → Read More: Trial Set to Test Inhaled mRNA for Viral Infections
By Alan, on November 27th, 2023%
A vaccine delivered with a patch device is shown in a clinical trial to generate neutralizing antibodies against measles and rubella similar to conventional injections. . . . → Read More: Vaccine Patch Shown Safe, Produces Measles/Rubella Antibodies
By Alan, on November 25th, 2023%
According to CB Insights, venture investments in A.I. are declining each quarter in 2023, with the number of venture deals reaching a low level not seen since 2017. . . . → Read More: Infographic: A.I. Getting Hype, But Fewer Venture Funds
By Alan, on November 24th, 2023%
Researchers from university labs in the U.K. are developing models of brain cell interactions using a company’s synthetic human cells derived from stem cells. . . . → Read More: Academic, Industry Labs to Build Brain Cell Models
By Alan, on November 22nd, 2023%
A company producing tissue samples in the lab, for drug discovery and preclinical research with robotics and artificial intelligence, raised $38 million in seed funding. . . . → Read More: Lab-Grown Tissue Company Gains $38M in Seed Funds
By Alan, on November 21st, 2023%
A challenge competition with a $50 million purse seeks new strategies to attack the global substance abuse epidemic, including personalized diagnostics and treatments. . . . → Read More: Challenge Seeks Precise Addiction Strategies, Biomarkers, Treatments
By Alan, on November 20th, 2023%
Data from three health repositories show a simple blood test reveals inherited and acquired genetic indicators, analyzed with artificial intelligence, to detect coronary heart disease. . . . → Read More: A.I. Analytics Show Blood Test Detects Heart Disease
By Alan, on November 18th, 2023%
China and India provided more than half of all international students at U.S. universities in the last academic year, as total enrollment from overseas approached pre-pandemic levels. . . . → Read More: Infographic – China, India Continue as Top Student Sources
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|